Announcements

22.10.2019

Warning regarding Esillaa slimmers’ tea

Swissmedic is issuing a warning regarding the slimming product Esillaa.

30.09.2019

Fixed texts for medicinal products which are being reallocated from dispensing category C to B as of 2019

Adaptation of fixed texts for medicinal products that may continue to be dispensed by pharmacies without a medical prescription after expert advice.

27.09.2019

Training course for regulatory authorities in low- and middle-income countries

Regulatory Training Workshops – a partnership for better health

26.09.2019

Anti-rabies vaccines: Supply problems until at least 2020

Temporary modification of the vaccine recommendations by the FOPH

23.09.2019

Recall of all preparations containing ranitidine from the Swiss market

Gastric acid blocker contaminated with traces of NDMA – use available alternative treatments for this indication.

18.09.2019

Investigation into the company Cryo-Save

Presumption of innocence principle applies to the parties concerned

26.07.2019

Swissmedic laboratory publishes updated test method for nitrosamines in sartans

Safety-limit testing for the nitrosamines NDMA and NDEA using single-quadrupole GC-MS

15.07.2019

Medicinal products with orphan drug status

Eligibility for procedure with prior notification and modification of billing practice for fast-track authorisation procedure

14.06.2019

Revision of therapeutic products legislation: list of medicinal products reallocated from dispensing category C to dispensing category B

Monthly publication of legally approved reclassifications in accordance with Art. 45, para. 3 TPO as of June 2019

22.10.2019

Warning regarding Esillaa slimmers’ tea

Swissmedic is issuing a warning regarding the slimming product Esillaa.

30.09.2019

Fixed texts for medicinal products which are being reallocated from dispensing category C to B as of 2019

Adaptation of fixed texts for medicinal products that may continue to be dispensed by pharmacies without a medical prescription after expert advice.

27.09.2019

Training course for regulatory authorities in low- and middle-income countries

Regulatory Training Workshops – a partnership for better health

26.09.2019

Anti-rabies vaccines: Supply problems until at least 2020

Temporary modification of the vaccine recommendations by the FOPH

23.09.2019

Recall of all preparations containing ranitidine from the Swiss market

Gastric acid blocker contaminated with traces of NDMA – use available alternative treatments for this indication.

18.09.2019

Investigation into the company Cryo-Save

Presumption of innocence principle applies to the parties concerned

26.07.2019

Swissmedic laboratory publishes updated test method for nitrosamines in sartans

Safety-limit testing for the nitrosamines NDMA and NDEA using single-quadrupole GC-MS

15.07.2019

Medicinal products with orphan drug status

Eligibility for procedure with prior notification and modification of billing practice for fast-track authorisation procedure

14.06.2019

Revision of therapeutic products legislation: list of medicinal products reallocated from dispensing category C to dispensing category B

Monthly publication of legally approved reclassifications in accordance with Art. 45, para. 3 TPO as of June 2019

Last modification 16.11.2017

Top of page